Treatment of cytomegalovirus infection

Details Treatment of cytomegalovirus infection Treatment of cytomegalovirus infection

A - Human Necessities

61

K

A61K 38/08 (2006.01) A61K 38/10 (2006.01) A61K 38/16 (2006.01) C07K 7/06 (2006.01) C07K 7/08 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2152373

Described herein are anti-cytomegalovirus peptides. In a preferred embodiment, the peptide is acetyl-[D-Arg]9-NH2. The use of these peptides, either per se or in combination with other anti-CMV compounds, is disclosed as an effective method for controlling CMV infection.

L'invention concerne des peptides anti-cytomégalovirus (CMV). Dans un mode de réalisation préféré, le peptide est l'acétyle-[D-Arg]¿9?-NH¿2?. L'invention concerne également l'utilisation desdits peptides, soit individuellement, soit combinés à d'autres composés anti-CMV, en tant que procédé efficace de lutte contre l'infection provoquée par le CMV.

Affiliated with

Also associated with

Rating

Treatment of cytomegalovirus infection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of cytomegalovirus infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of cytomegalovirus infection will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1350829